Exploring how ACE2 genetic variants influence COVID-19 susceptibility and why they're not the primary factor determining disease severity.
Discover how CD48 protein dysregulation in COVID-19 patients reveals new insights into severe disease progression and potential therapeutic targets.
Understanding reactogenicity and immunogenicity of Pfizer and AstraZeneca COVID-19 vaccines. Learn how side effects relate to immune protection.
Exploring the role of chitotriosidase enzyme in COVID-19 lung injury and its potential as a therapeutic target for pulmonary fibrosis.